الفهرس 
AbstractOnly 14 pages are availabe for public view
 |  | from | 116 |  |  |
| | | from | 116 | | |
Abstract
from the results of these chapters, it can be concluded that:
The assay of FMT can be carried out using UV-spectrophotometer at λmax 286.
The addition of 1 % w/v PVP (preparation of ternary system) enhance the dissolution of binary systems.
Thermal analysis of FMT-binary systems using DSC and TGA showed loss of weight (about 6 %) combined with an endothermic peak at about 58.8 oc and were attributed to the water loss from β-CyD. However, the melting point of the drug appeared in its normal position. Similar results were obtained upon using HP-β-CyD.
The analysis of the prepared samples using FTIR or 1HNMR showed that there is no chemical interaction between the drug and the used CyD.
The prepared ternary systems showed the significant high dissolution rate when it compared with the dissolution of the drug.
Capsules contain FMT (formula 1), FMT+ β-CyD+ PVP (formula 2) and FMT+ β-CyD+ PVP (formula 3) were prepared. The disintegration times of these prepared capsules were within the limit specify on USP.
The drug release from the prepared capsules showed significant and fasting the release of FMT from capsules of formula 2 upon comparing with the capsules of formula 1.
The capsules of formula 3 showed higher and significant drug release upon comparing with the capsules of formula 2.
The clinical study was carried out on 60 patients and clearly showed that, there is a significant difference between formula 1 and either of formula 2 or formula 3. Interestingly, there was no significant difference between the therapeutic effect after the administration of capsules of formula 2 and that of formula 3.